229 related articles for article (PubMed ID: 7958493)
41. Abnormal transient rise in hepatic glucose production after oral glucose in non-insulin-dependent diabetic subjects.
Thorburn A; Litchfield A; Fabris S; Proietto J
Diabetes Res Clin Pract; 1995 May; 28(2):127-35. PubMed ID: 7587920
[TBL] [Abstract][Full Text] [Related]
42. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM.
Reaven GM; Hollenbeck C; Jeng CY; Wu MS; Chen YD
Diabetes; 1988 Aug; 37(8):1020-4. PubMed ID: 3292322
[TBL] [Abstract][Full Text] [Related]
43. [Effect of caffeine on various metabolic parameters in vivo].
Sachs M; Förster H
Z Ernahrungswiss; 1984 Sep; 23(3):181-205. PubMed ID: 6390995
[TBL] [Abstract][Full Text] [Related]
44. Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patients.
Golay A; DeFronzo RA; Ferrannini E; Simonson DC; Thorin D; Acheson K; Thiébaud D; Curchod B; Jéquier E; Felber JP
Diabetologia; 1988 Aug; 31(8):585-91. PubMed ID: 3065112
[TBL] [Abstract][Full Text] [Related]
45. Improvement with metformin in insulin internalization and processing in monocytes from NIDDM patients.
Benzi L; Trischitta V; Ciccarone A; Cecchetti P; Brunetti A; Squatrito S; Marchetti P; Vigneri R; Navalesi R
Diabetes; 1990 Jul; 39(7):844-9. PubMed ID: 2191888
[TBL] [Abstract][Full Text] [Related]
46. Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM.
Mitrakou A; Kelley D; Veneman T; Jenssen T; Pangburn T; Reilly J; Gerich J
Diabetes; 1990 Nov; 39(11):1381-90. PubMed ID: 2121568
[TBL] [Abstract][Full Text] [Related]
47. Insulin and glucose levels and prevalence of glucose intolerance in pedigrees with multiple diabetic siblings.
Elbein SC; Maxwell TM; Schumacher MC
Diabetes; 1991 Aug; 40(8):1024-32. PubMed ID: 1860554
[TBL] [Abstract][Full Text] [Related]
48. Effect of 6 months' gliclazide treatment on insulin release and sensitivity to endogenous insulin in NIDDM: role of initial CSII-induced normoglycemia.
Della Casa L; del Rio G; Glaser B; Cerasi E
Diabetes Res Clin Pract; 1991; 14 Suppl 2():S69-78. PubMed ID: 1794269
[TBL] [Abstract][Full Text] [Related]
49. Effects of massive obesity on insulin sensitivity and insulin clearance and the metabolic response to insulin as assessed by the euglycemic clamp technique.
Zuniga-Guajardo S; Jimenez J; Angel A; Zinman B
Metabolism; 1986 Mar; 35(3):278-82. PubMed ID: 3512959
[TBL] [Abstract][Full Text] [Related]
50. The metabolic response to the euglycemic insulin clamp in type I diabetes and normal humans.
Zuniga-Guajardo S; Zinman B
Metabolism; 1985 Oct; 34(10):926-30. PubMed ID: 3900631
[TBL] [Abstract][Full Text] [Related]
51. Energy and substrate metabolism in obesity and postobese state.
Tappy L; Felber JP; Jéquier E
Diabetes Care; 1991 Dec; 14(12):1180-8. PubMed ID: 1773703
[TBL] [Abstract][Full Text] [Related]
52. Determinants of mild fasting hypertriglyceridaemia in non-insulin-dependent diabetes.
Baynes C; Henderson AD; Hughes CL; Richmond W; Johnston DG; Elkeles RS
J Intern Med; 1991 Mar; 229(3):267-73. PubMed ID: 2007844
[TBL] [Abstract][Full Text] [Related]
53. Insulin-mediated glucose uptake in nondialyzed and dialyzed uremic insulin-dependent diabetic subjects.
Schmitz O
Diabetes; 1985 Nov; 34(11):1152-9. PubMed ID: 3899812
[TBL] [Abstract][Full Text] [Related]
54. Glucose utilization during exercise in normal and diabetic subjects. The role of insulin.
Krzentowski G; Pirnay F; Pallikarakis N; Luyckx AS; Lacroix M; Mosora F; Lefèbvre PJ
Diabetes; 1981 Dec; 30(12):983-9. PubMed ID: 7030833
[No Abstract] [Full Text] [Related]
55. Serum ketone response to glucagon as a marker of insulin dependency in diabetics.
Watanabe T; Sugiyama H; Uchimura I; Maezawa H
Diabetes Res Clin Pract; 1991 Nov; 14(2):107-12. PubMed ID: 1756681
[TBL] [Abstract][Full Text] [Related]
56. Metabolic basis of obesity and noninsulin-dependent diabetes mellitus.
Golay A; Felber JP; Jequier E; DeFronzo RA; Ferrannini E
Diabetes Metab Rev; 1988 Dec; 4(8):727-47. PubMed ID: 3069401
[No Abstract] [Full Text] [Related]
57. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM.
Consoli A; Nurjhan N; Capani F; Gerich J
Diabetes; 1989 May; 38(5):550-7. PubMed ID: 2653926
[TBL] [Abstract][Full Text] [Related]
58. Effect of insulin on oxidation of intracellularly and extracellularly derived glucose in patients with NIDDM. Evidence for primary defect in glucose transport and/or phosphorylation but not oxidation.
Butler PC; Kryshak EJ; Marsh M; Rizza RA
Diabetes; 1990 Nov; 39(11):1373-80. PubMed ID: 2121567
[TBL] [Abstract][Full Text] [Related]
59. Effects of BAYm 1099, new alpha-glucosidase inhibitor, on acute metabolic responses and metabolic control in NIDDM over 1 mo.
Samad AH; Ty Willing TS; Alberti KG; Taylor R
Diabetes Care; 1988 Apr; 11(4):337-44. PubMed ID: 3042310
[TBL] [Abstract][Full Text] [Related]
60. Increased rate of Cori cycle in obese subjects with NIDDM and effect of weight reduction.
Zawadzki JK; Wolfe RR; Mott DM; Lillioja S; Howard BV; Bogardus C
Diabetes; 1988 Feb; 37(2):154-9. PubMed ID: 3391340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
